JPRN-UMIN000009421
Recruiting
未知
Efficacy and safety of rituximab for intractable immunogenic neurological disorder in children - rituximab for pediatric neurological disorder
Department of Pediatrics, Kobe Universtiy Graduate School of Medicine0 sites10 target enrollmentNovember 28, 2012
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Pediatrics, Kobe Universtiy Graduate School of Medicine
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patients 1\) are affected for infectious disease, 2\) are recieved live vaccine within 4weeks, 3\) are suffered from heart, lung, liver and kidney disease, 4\) have the allergy for rituximab, 5\) are ruled unfit to this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitisEUCTR2018-000637-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)106
Not yet recruiting
Not Applicable
A study to compare the effectiveness of two drugs, one given orally (tacrolimus) and another as injection (rituximab) in preventing disease recurrences (relapses) in children with frequent relapses of nephrotic syndrome, a kidney disease characterized by protein losses in the urine.CTRI/2018/11/016342Intas Pharmaceuticals Ltd
Completed
Not Applicable
Efficacy and safety of rituximab for patients with severe rheumatic diseaseChildhood-onset severe rheumatic disease (systemic lupus erhythematosus, dermatomyositis, poly myositis, systemic sclerosis , mixed connective tissue disease, Sjogren's syndrome, anti-phospholipid syndrome)JPRN-UMIN000018376Yokohama City University Hospital Department of Pediatrics20
Completed
Not Applicable
A study of the efficacy and safety to rituximab in treating adult onset refractory nephrotic syndromeRefractory nephrotic syndromeJPRN-UMIN000021143Fujita Health University School of Medicine, Department of Nephrology10
Active, not recruiting
Not Applicable
Efficacy and safety of rituximab in patients with rheumatoid arthritis - FIRSTRheumatoid arthritisMedDRA version: 8.1Level: PTClassification code 10039073Term: Rheumatoid arthritisEUCTR2006-001000-37-DERoche Pharma AG300